Maile Biopharmaceutical is an innovative high-tech biopharmaceutical enterprise, focusing on the research and development, production, and sales of high-tech pharmaceutical products.
The company holds the production, operation, and sales rights for Xibofen, a Class 1 new drug approved by *NMPA for tumor-PDT treatment.
The company's sales center and an independent drug R&D center under construction are located in Chengdu City, Sichuan Province. Its manufacturing plant is located in Chongqing, and the company has four sales branches in Beijing, Shanghai, Guangzhou, and Wuhan.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
